Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Italy Probes European Pharma Giants Novartis, Roche Over Eye Drug Competition Allegations
June 06, 2024
Tickers
NEWS
NVS
RHHBY
Tags
AI Generated
Top Stories
Health Care
From
Benzinga
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
May 29, 2024
Tickers
ARKG
ARKK
DNA
RHHBY
Tags
ARKG
DNA
Recent Press Releases
From
Motley Fool
If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today
May 26, 2024
Tickers
GS
RHHBY
VKTX
Tags
VKTX
RHHBY
Market News
From
Motley Fool
Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma Companies
May 23, 2024
Tickers
AZN
GEHC
JNJ
PFE
Tags
RHHBY
AZN
Market News
From
Benzinga
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
May 21, 2024
Tickers
BHVN
GPCR
LLY
NEWS
Tags
obesity
Benzinga
Biotech
From
Benzinga
Roche To Ride Booming Obesity Treatment Market With Newly-Acquired Drug Candidate
May 16, 2024
Tickers
NEWS
RHHBY
Tags
Market News
RHHBY
Health Care
From
Benzinga
Can Ocugen Stock Keep Churning Higher?
April 29, 2024
Tickers
OCGN
RHHBY
VHT
Tags
Recent Press Releases
Market News
OCGN
From
Motley Fool
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
April 24, 2024
Tickers
GILD
HOOK
NEWS
RHHBY
Tags
why it's moving
RHHBY
GILD
From
Benzinga
2 Small-Cap Growth Stocks With Room To Run
April 24, 2024
Tickers
ACHR
OCUL
REGN
RHHBY
Tags
OCUL
REGN
RHHBY
From
Motley Fool
Roche's Lymphoma Drug With Chemo Extends Survival In Pretreated Patients
April 15, 2024
Tickers
HOOK
NEWS
RHHBY
RPTX
Tags
Briefs
Stories That Matter
Benzinga
From
Benzinga
Looking for an Easy Way to Earn Passive Income? This Vanguard ETF Pays a Dividend Yield of Nearly 4.9%.
April 14, 2024
Tickers
HSBC
NVS
RHHBY
SHEL
Tags
VYMI
Recent Press Releases
TM
From
Motley Fool
Why Roche Holdings Stock Popped Today
April 11, 2024
Tickers
LLY
RHHBY
Tags
RHHBY
LLY
Market News
From
Motley Fool
Can Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take.
April 10, 2024
Tickers
RHHBY
RXRX
Tags
RHHBY
BAYR/Y
Market News
From
Motley Fool
Analysts Express Confidence in Alnylam's Hypertension Drug Despite Mixed Trial Data
April 08, 2024
Tickers
ALNY
NEWS
RHHBY
Tags
Market News
Analyst Color
RHHBY
From
Benzinga
Hot Stocks: The 3 Best Opportunities for Investing in Weight Loss Drugs
March 22, 2024
Tickers
LLY
REGN
RHHBY
Tags
REGN
Stocks to Buy
NYSE:LLY,NASDAQ:REGN,OTCMKTS:RHHBY
From
InvestorPlace
Why Is European Pharma Giant Argenx Valued At Over $20B Trading Higher On Thursday?
March 21, 2024
Tickers
ARGX
JNJ
NEWS
RHHBY
Tags
Health Care
JNJ
News
From
Benzinga
Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche's US Facility Acquisition For $1.2B
March 20, 2024
Tickers
LZAGF
LZAGY
NEWS
RHHBY
Tags
News
Health Care
LZAGF
From
Benzinga
FDA Approves BeiGene's First Drug Candidate Produced Through Its Immuno-Oncology Program For Esophageal Cancer
March 15, 2024
Tickers
BGNE
NEWS
NVS
RHHBY
Tags
Health Care
News
Large Cap
From
Benzinga
Top Wall Street Analysts Flag US Market Concentration Anxiety, Advise Investors To Adopt 'Barbell Approach'
March 11, 2024
Tickers
ASIA
ASML
AZN
GSK
Tags
GSK
Emerging Markets
Equities
From
Benzinga
FDA Conditionally Approves Expanded Use Of BeiGene's Combination Drug For Certain Type Of Blood Cancer
March 08, 2024
Tickers
ABBV
BGNE
GILD
NEWS
Tags
FDA
General
Biotech
From
Benzinga
Roche/Alnylam Blood Pressure Drug Aces In Mid-Stage Trial, Analyst Says Zilebesiran As Promising Opportunity In Addressing Global Hypertension Challenges
March 05, 2024
Tickers
ALNY
NEWS
RHHBY
Tags
Analyst Ratings
RHHBY
Analyst Color
From
Benzinga
11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
February 28, 2024
Tickers
ASML
AZN
GSK
LRLCY
Tags
Benzinga
ETFs
LVMHF
From
Benzinga
This Drug By Roche And Novartis Reduces Allergic Reactions Across Multiple Foods For People With Food Allergies
February 26, 2024
Tickers
NEWS
NVS
RHHBY
Tags
Health Care
Large Cap
News
From
Benzinga
Move Over Magnificent 7, Say Hello to the GRANOLAS
February 22, 2024
Tickers
AZN
GLAXF
LRLCY
LVMUY
Tags
LVMUY
Stocks to Buy
RHHBY
From
InvestorPlace
FDA Fast-Tracks Review Of Sarepta's Groundbreaking Muscular Dystrophy Treatment With $1B Market In Sight
February 16, 2024
Tickers
NEWS
RHHBY
SRPT
Tags
Health Care
Trading Ideas
Large Cap
From
Benzinga
Monte Rosa Therapeutics' AI And Machine Learning Platform Is Adding Significant Value Creation in Cancer Research: Analyst
February 15, 2024
Tickers
GLUE
NEWS
RHHBY
Tags
Market News
Analyst Color
RHHBY
From
Benzinga
Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month
February 13, 2024
Tickers
HOOK
NEWS
RHHBY
RPTX
Tags
Briefs
Benzinga
Stories That Matter
From
Benzinga
Roche Walks Away From HOOKIPA Pharma-Partnered KRAS-Focused Cancer Deal
January 29, 2024
Tickers
GILD
HOOK
MRK
NEWS
Tags
General
Movers
Biotech
From
Benzinga
Roche's One Of Largest Selling Cancer Drug Approved Under The Skin Injection Version In Europe
January 16, 2024
Tickers
HALO
RHHBY
Tags
Biotech
Benzinga
Health Care
From
Benzinga
Merck's Crown Jewel Cancer Drug Keytruda Scores FDA Approval For Third Indication In Cervical Cancer
January 16, 2024
Tickers
MRK
NEWS
RHHBY
Tags
Briefs
Benzinga
Biotech
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.